Toolabi K, et al. - Patients who underwent laparoscopic roux-en-Y gastric bypass (LRYGB) or LSG were examined for the amount of weight loss and weight regain and also remission rate of obesity-related comorbidities including diabetes mellitus (DM), hypertension (HTN), and dyslipidemia during 5 years of follow-up. Among the 120 enrolled patients who underwent LRYGB or LSG from 2011 to 2013, researchers observed similar percent weight loss and percentage of excess weight loss between two procedures at 1 year following operation. With respect to the 5-year success rate of these two techniques, LRYGB vs LSG seems to be superior, as it was associated with lower weight regain and higher weight loss. They observed comparable short- and long-term effects of two procedures on remission of comorbidities.